Uniplan Investment Counsel’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
2023
Q2
$1.34M Sell
2023
Q1
$778K Sell
2022
Q4
$799K Sell
2022
Q3
$2.56M Sell
2022
Q2
$1.7M Buy
2022
Q1
$1.31M Buy
2021
Q4
$2.53M Buy
2021
Q3
$3.73M Sell
2021
Q2
$4.09M Buy
2021
Q1
$7.63M Sell
2020
Q4
$3.04M Sell
2020
Q3
$1.9M Buy
2020
Q2
$1.37M Sell
2020
Q1
$1.01M Buy
2019
Q4
$890K Buy
2019
Q3
$604K Sell
2019
Q2
$1.52M Buy